Our Therapeutic Antibody Discovery Platforms
Access a full suite of technologies that transform the transgenic animal approach to the discovery of fully human antibodies
Learn about our computationally powered antigen design platform for challenging therapeutic targets.
World-class transgenic animals for the generation of naturally optimized human antibodies® in multiple modalities.
Robust high-throughput screening enables deep searches into immune repertoires to identify unique antibodies with a superior target profile.
Leverage the full suite of OmniAb technologies for enhanced discovery and optimization.
Partnerships with Contract Research Organizations (CROs)
OmniAb works with a comprehensive network of international contract research organizations (CROs) with substantial experience generating OmniAb antibodies and with expertise in characterization, bioinformatics, cell line development, and GMP manufacturing. Current CROs include:
